Regional differences in gastrointestinal processing and absorption of epidermal growth factor in suckling rats

Radhakrishna Rao, O. Koldovsky, J. Grimes, C. Williams, T. P. Davis

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Gastrointestinal processing and absorption in vivo of 125I-labeled epidermal growth factor (125I-EGF) was studied in isolated stomach, jejunum, and ileum of 12-day-old suckling rats. Dose dependency and regional differences in the processing and absorption of EGF were determined. At 60 min after administration of 125I-EGF into the isolated gastric lumen, >90% of radioactive material was recovered from gastric wall and lumen in both suckling and weanling rats. On the other hand, a considerable amount of EGF was absorbed (in immunoreactive and receptor active form) from isolated jejunum and ileum of suckling rats. The absorption of EGF from isolated jejunum and ileum increased linearly with the dose of EGF administered up to 1 μg/rat; absorption of orogastrically administered EGF was also increased linearly with the dose of EGF administered (up to 5 μg/rat). Reverse-phase high-performance liquid chromatographic analysis of tissue extracts demonstrated that 125I-EGF is stable in gastric lumen but only partially stable in the jejunal lumen. Carboxy-terminally processed forms of EGF were detected in the luminal flushings of jejunum and ileum and in the wall of the stomach, jejunum, and ileum. 125I-des(48-53)EGF was found in ileal flushings and in the walls of the stomach, jejunum, and ileum, whereas 125I-des(53)EGF and 125I-des(49-53)EGF were detected in jejunal flushings. Receptor binding of 125I-des(53)EGF was significantly greater (by 57%) than that of intact 125I-EGF, but receptor binding of 125I-des(49-53)EGF and 125I-des(48-53)EGF was greatly diminished by 57 and 86%, respectively. These studies demonstrate the existence of a high capacity and regional differences in the gastrointestinal absorption of EGF. Furthermore, EGF undergoes carboxy-terminal processing in the gastrointestinal tract during its absorption.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume261
Issue number5 24-5
StatePublished - 1991
Externally publishedYes

Fingerprint

Epidermal Growth Factor
Jejunum
Ileum
Stomach
Gastrointestinal Absorption
Tissue Extracts
Reverse-Phase Chromatography
Epidermal Growth Factor Receptor

All Science Journal Classification (ASJC) codes

  • Physiology
  • Gastroenterology

Cite this

Regional differences in gastrointestinal processing and absorption of epidermal growth factor in suckling rats. / Rao, Radhakrishna; Koldovsky, O.; Grimes, J.; Williams, C.; Davis, T. P.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 261, No. 5 24-5, 1991.

Research output: Contribution to journalArticle

@article{cd973896a781416caa3b66cb97150000,
title = "Regional differences in gastrointestinal processing and absorption of epidermal growth factor in suckling rats",
abstract = "Gastrointestinal processing and absorption in vivo of 125I-labeled epidermal growth factor (125I-EGF) was studied in isolated stomach, jejunum, and ileum of 12-day-old suckling rats. Dose dependency and regional differences in the processing and absorption of EGF were determined. At 60 min after administration of 125I-EGF into the isolated gastric lumen, >90{\%} of radioactive material was recovered from gastric wall and lumen in both suckling and weanling rats. On the other hand, a considerable amount of EGF was absorbed (in immunoreactive and receptor active form) from isolated jejunum and ileum of suckling rats. The absorption of EGF from isolated jejunum and ileum increased linearly with the dose of EGF administered up to 1 μg/rat; absorption of orogastrically administered EGF was also increased linearly with the dose of EGF administered (up to 5 μg/rat). Reverse-phase high-performance liquid chromatographic analysis of tissue extracts demonstrated that 125I-EGF is stable in gastric lumen but only partially stable in the jejunal lumen. Carboxy-terminally processed forms of EGF were detected in the luminal flushings of jejunum and ileum and in the wall of the stomach, jejunum, and ileum. 125I-des(48-53)EGF was found in ileal flushings and in the walls of the stomach, jejunum, and ileum, whereas 125I-des(53)EGF and 125I-des(49-53)EGF were detected in jejunal flushings. Receptor binding of 125I-des(53)EGF was significantly greater (by 57{\%}) than that of intact 125I-EGF, but receptor binding of 125I-des(49-53)EGF and 125I-des(48-53)EGF was greatly diminished by 57 and 86{\%}, respectively. These studies demonstrate the existence of a high capacity and regional differences in the gastrointestinal absorption of EGF. Furthermore, EGF undergoes carboxy-terminal processing in the gastrointestinal tract during its absorption.",
author = "Radhakrishna Rao and O. Koldovsky and J. Grimes and C. Williams and Davis, {T. P.}",
year = "1991",
language = "English (US)",
volume = "261",
journal = "American Journal of Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5 24-5",

}

TY - JOUR

T1 - Regional differences in gastrointestinal processing and absorption of epidermal growth factor in suckling rats

AU - Rao, Radhakrishna

AU - Koldovsky, O.

AU - Grimes, J.

AU - Williams, C.

AU - Davis, T. P.

PY - 1991

Y1 - 1991

N2 - Gastrointestinal processing and absorption in vivo of 125I-labeled epidermal growth factor (125I-EGF) was studied in isolated stomach, jejunum, and ileum of 12-day-old suckling rats. Dose dependency and regional differences in the processing and absorption of EGF were determined. At 60 min after administration of 125I-EGF into the isolated gastric lumen, >90% of radioactive material was recovered from gastric wall and lumen in both suckling and weanling rats. On the other hand, a considerable amount of EGF was absorbed (in immunoreactive and receptor active form) from isolated jejunum and ileum of suckling rats. The absorption of EGF from isolated jejunum and ileum increased linearly with the dose of EGF administered up to 1 μg/rat; absorption of orogastrically administered EGF was also increased linearly with the dose of EGF administered (up to 5 μg/rat). Reverse-phase high-performance liquid chromatographic analysis of tissue extracts demonstrated that 125I-EGF is stable in gastric lumen but only partially stable in the jejunal lumen. Carboxy-terminally processed forms of EGF were detected in the luminal flushings of jejunum and ileum and in the wall of the stomach, jejunum, and ileum. 125I-des(48-53)EGF was found in ileal flushings and in the walls of the stomach, jejunum, and ileum, whereas 125I-des(53)EGF and 125I-des(49-53)EGF were detected in jejunal flushings. Receptor binding of 125I-des(53)EGF was significantly greater (by 57%) than that of intact 125I-EGF, but receptor binding of 125I-des(49-53)EGF and 125I-des(48-53)EGF was greatly diminished by 57 and 86%, respectively. These studies demonstrate the existence of a high capacity and regional differences in the gastrointestinal absorption of EGF. Furthermore, EGF undergoes carboxy-terminal processing in the gastrointestinal tract during its absorption.

AB - Gastrointestinal processing and absorption in vivo of 125I-labeled epidermal growth factor (125I-EGF) was studied in isolated stomach, jejunum, and ileum of 12-day-old suckling rats. Dose dependency and regional differences in the processing and absorption of EGF were determined. At 60 min after administration of 125I-EGF into the isolated gastric lumen, >90% of radioactive material was recovered from gastric wall and lumen in both suckling and weanling rats. On the other hand, a considerable amount of EGF was absorbed (in immunoreactive and receptor active form) from isolated jejunum and ileum of suckling rats. The absorption of EGF from isolated jejunum and ileum increased linearly with the dose of EGF administered up to 1 μg/rat; absorption of orogastrically administered EGF was also increased linearly with the dose of EGF administered (up to 5 μg/rat). Reverse-phase high-performance liquid chromatographic analysis of tissue extracts demonstrated that 125I-EGF is stable in gastric lumen but only partially stable in the jejunal lumen. Carboxy-terminally processed forms of EGF were detected in the luminal flushings of jejunum and ileum and in the wall of the stomach, jejunum, and ileum. 125I-des(48-53)EGF was found in ileal flushings and in the walls of the stomach, jejunum, and ileum, whereas 125I-des(53)EGF and 125I-des(49-53)EGF were detected in jejunal flushings. Receptor binding of 125I-des(53)EGF was significantly greater (by 57%) than that of intact 125I-EGF, but receptor binding of 125I-des(49-53)EGF and 125I-des(48-53)EGF was greatly diminished by 57 and 86%, respectively. These studies demonstrate the existence of a high capacity and regional differences in the gastrointestinal absorption of EGF. Furthermore, EGF undergoes carboxy-terminal processing in the gastrointestinal tract during its absorption.

UR - http://www.scopus.com/inward/record.url?scp=0026344065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026344065&partnerID=8YFLogxK

M3 - Article

VL - 261

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1931-857X

IS - 5 24-5

ER -